Roivant Sciences Ltd [NASDAQ: ROIV] gained 0.56% on the last trading session, reaching $10.87 price per share at the time. The company report on January 30, 2024 at 4:05 PM that Roivant to Report Financial Results for the Third Quarter Ended December 31, 2023, and Provide Business Update on Tuesday, February 13, 2024.
To access the conference call by phone, please register online using this registration link. The presentation and webcast details will also be available under “Events & Presentations” in the Investors section of the Roivant website at https://investor.roivant.com/news-events/events. The archived webcast will be available on Roivant’s website after the conference call.
If compared to the average trading volume of 1.27 shares, ROIV reached a trading volume of 6797221 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Roivant Sciences Ltd [ROIV]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ROIV shares is $16.20 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ROIV stock is a recommendation set at 1.17. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Piper Sandler have made an estimate for Roivant Sciences Ltd shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on January 05, 2024.
The Average True Range (ATR) for Roivant Sciences Ltd is set at 0.37, with the Price to Sales ratio for ROIV stock in the period of the last 12 months amounting to 84.72. The Price to Book ratio for the last quarter was 9.18, with the Price to Cash per share for the same quarter was set at 1.76.
Trading performance analysis for ROIV stock
Roivant Sciences Ltd [ROIV] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 8.48. With this latest performance, ROIV shares dropped by -1.09% in over the last four-week period, additionally sinking by -6.05% over the last 6 months – not to mention a rise of 40.08% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ROIV stock in for the last two-week period is set at 59.28, with the RSI for the last a single of trading hit 66.63, and the three-weeks RSI is set at 56.26 for Roivant Sciences Ltd [ROIV]. The present Moving Average for the last 50 days of trading for this stock 10.58, while it was recorded at 10.59 for the last single week of trading, and 10.26 for the last 200 days.
Roivant Sciences Ltd [ROIV]: A deeper dive into fundamental analysis
Roivant Sciences Ltd’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.82 and a Current Ratio set at 5.84.
Roivant Sciences Ltd [ROIV]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Roivant Sciences Ltd posted -0.49/share EPS, while the average EPS was predicted by analysts to be reported at -0.39/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -25.60%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ROIV.
An analysis of Institutional ownership at Roivant Sciences Ltd [ROIV]
The top three institutional holders of ROIV stocks are: VANGUARD GROUP INC with ownership of 1.3 billion shares, which is approximately 8.2815%. BLACKROCK INC., holding 1.03 billion shares of the stock with an approximate value of $176.59 billion in ROIV stocks shares; and BERKSHIRE HATHAWAY INC, currently with $156.75 billion in ROIV stock with ownership which is approximately 5.8325%.
